Press Release: Cerus Endovascular (“Cerus”), a medical technology company that makes products to treat haemorrhagic strokes, has announced its acquisition by Stryker Corporation, one of the world’s leading medical technology companies. Cerus’ products, Contour and Neqstent, have been successful in treating brain aneurysms. Aneurysms are weaknesses in the blood vessel wall, which can bleed or […]
Read More15x+ return for SPARK Impact-managed North West Fund for Biomedical
Posted on May 9, 2023.